CuraGen Corporation
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer (NCT00704158) | CuraGen Corporation | 2008-06-01 |
| A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma (NCT00412828) | CuraGen Corporation | 2006-06-01 |
| A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis (NCT00323518) | CuraGen Corporation | 2006-05-01 |
| Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant (NCT00104065) | CuraGen Corporation | 2005-01-01 |
Track CuraGen Corporation automatically
Every clearance here is in the API, with alerts when new ones post.